The FGF family: biology, pathophysiology and therapy

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837

Thalidomide is an inhibitor of angiogenesis.

D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440

FGF-21 as a novel metabolic regulator

Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,089

Suppression of Aging in Mice by the Hormone Klotho

Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865

Klotho converts canonical FGF receptor into a specific receptor for FGF23

Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh‐Hain, J. A., Tamez, H. E., Shah, A., Smith, K. T., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,729

Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21

Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504

Molecular mechanisms and clinical applications of angiogenesis

Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467

Basic and Therapeutic Aspects of Angiogenesis

Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771

Fibroblast growth factor signalling: from development to cancer

Turner, N. C., & Grose, R. P. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2780 · Cited by 2,768

Recent advances in bone tissue engineering scaffolds

Bose, S., Roy, M., & Bandyopadhyay, A. K. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.07.005 · Cited by 2,217

The Fibroblast Growth Factor signaling pathway

Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050

Osteoarthritis: pathogenic signaling pathways and therapeutic targets

Yao, Q., Wu, X., Tao, C., Gong, W., Chen, M., Qu, M., Zhong, Y., He, T., Chen, S., & Xiao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01330-w · Cited by 1,194

Advances and challenges in targeting FGFR signalling in cancer

Babina, I. S., & Turner, N. C. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.8 · Cited by 820

Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation

Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T., Fändriks, L., le Roux, C. W., Nielsen, J., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.009 · Cited by 757

Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease

Itoh, N., & Ornitz, D. M. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq121 · Cited by 726

FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis

Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., Xu, H. E., Shulman, G. I., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Science · doi:10.1126/science.1198363 · Cited by 637

FGF Receptors: Cancer Biology and Therapeutics

Katoh, M., & Nakagama, H. (2013) · Medicinal Research Reviews · doi:10.1002/med.21288 · Cited by 620

Cellular bioenergetics as a target for obesity therapy

Tseng, Y.-H., Cypess, A. M., & Kahn, C. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3138 · Cited by 591

Exploring mechanisms of FGF signalling through the lens of structural biology

Goetz, R. M., & Mohammadi, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3528 · Cited by 597

Molecular targeted therapy for anticancer treatment

Min, H.-Y., & Lee, H.-Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00864-3 · Cited by 569

Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor

Zhao, Y., & Adjei, A. A. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0465 · Cited by 573

Fibroblast growth factors and their receptors in cancer

Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 543

Developmental pathways in the pathogenesis of lung fibrosis

Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., Langhe, S. D., & Thannickal, V. J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 525

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

Gotink, K. J., & Verheul, H. M. W. (2009) · Angiogenesis · doi:10.1007/s10456-009-9160-6 · Cited by 526

Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase

Guagnano, V., Furet, P., Spanka, C., Bordas, V., Douget, M. L., Stamm, C., Brueggen, J., Jensen, M. R., Schnell, C., SCHMID, H. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2006222 · Cited by 485

Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer

Brooks, A. N., Kilgour, E., & Smith, P. D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0699 · Cited by 461

Endocrine fibroblast growth factors 15/19 and 21: from feast to famine

Potthoff, M. J., Kliewer, S. A., & Mangelsdorf, D. J. (2012) · Genes & Development · doi:10.1101/gad.184788.111 · Cited by 442

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.9 · Cited by 424

Signaling pathways in obesity: mechanisms and therapeutic interventions

Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 490

Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives

Dieci, M. V., Arnedos, M., André, F., & Soria, J. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0362 · Cited by 417

FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)

Katoh, M. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2620 · Cited by 407

Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives

Lee, C., Kim, M., Kumar, A., Lee, H., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 484

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors

Tabernero, J. M., Bahleda, R., Dienstmann, R., Infante, J. R., Mita, A. C., Italiano, A., Calvo, E., Moreno, V., Adamo, B., Gazzah, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.7341 · Cited by 390

Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics

Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.12.036 · Cited by 394

The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration

Farooq, M., Khan, A. W., Kim, M. S., & Choi, S. (2021) · Cells · doi:10.3390/cells10113242 · Cited by 387

FGF signalling: diverse roles during early vertebrate embryogenesis

Dorey, K., & Amaya, E. (2010) · Development · doi:10.1242/dev.037689 · Cited by 347

Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Liu, J., Wang, Y., Akamatsu, Y., Lee, C. C., Stetler, R. A., Lawton, M. T., & Yang, G.-Y. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.004 · Cited by 335

Signaling networks in RUNX2‐dependent bone development

Komori, T. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22994 · Cited by 329

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

Qin, S., Li, A., Yi, M., Yu, S., Zhang, M., & Wu, K. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0718-5 · Cited by 335

Targeting angiogenesis in oncology, ophthalmology and beyond

Cao, Y., Langer, R., & Ferrara, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00671-z · Cited by 339

Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models

Gozgit, J. M., Wong, M. J., Moran, L. E., Wardwell, S., Mohemmad, Q. K., Narasimhan, N. I., Shakespeare, W. C., Wang, F., Clackson, T., & Rivera, V. M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0450 · Cited by 322

Roles of Fibroblast Growth Factor Receptors in Carcinogenesis

Haugsten, E. M., Więdłocha, A., Olsnes, S., & Wesche, J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0168 · Cited by 320

Pathways mediating VEGF-independent tumor angiogenesis

Ferrara, N. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.003 · Cited by 324

Facilitation of AMPA Receptor Synaptic Delivery as a Molecular Mechanism for Cognitive Enhancement

Knafo, S., Venero, C., Sánchez‐Puelles, C., Pereda-Pérez, I., Franco, A. C. G., Sandi, C., Suárez, L. M., Solís, J. M., Alonso‐Nanclares, L., Martín, E. D., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001262 · Cited by 313

Metabolic messengers: FGF21

Flippo, K. H., & Potthoff, M. J. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00354-2 · Cited by 311

Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances

Chen, X., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 347

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors

Dai, S., Zhou, Z. M., Chen, Z., Xu, G., & Chen, Y. (2019) · Cells · doi:10.3390/cells8060614 · Cited by 303

Alzheimer’s Disease: An Update and Insights Into Pathophysiology

Abubakar, M. B., Sanusi, K. O., Ugusman, A., Mohamed, W. M. Y., Kamal, H., Ibrahim, N. H., Khoo, C. S., & Kumar, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.742408 · Cited by 302

Skin regeneration scaffolds: a multimodal bottom-up approach

Yildirimer, L., Thanh, N. T. K., & Seifalian, A. M. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.08.004 · Cited by 284

Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21

Owen, B. M., Mangelsdorf, D. J., & Kliewer, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.002 · Cited by 286

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283

A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis

Jonker, J., Suh, J. M., Atkins, A., Ahmadian, M., Li, P., Whyte, J., He, M., Juguilon, H., Yin, Y.-Q., Phillips, C. T., et al. (2012) · Nature · doi:10.1038/nature10998 · Cited by 286

A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21

Kliewer, S. A., & Mangelsdorf, D. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.004 · Cited by 273

Growth Factor Engineering Strategies for Regenerative Medicine Applications

Ren, X., Zhao, M., Lash, B., Martino, M. M., & Julier, Z. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00469 · Cited by 277

Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and PathologyPreprint

Belov, A. A., & Mohammadi, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015958 · Cited by 278

Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer

Suh, J. M., Jonker, J. W., Ahmadian, M., Goetz, R. M., Lackey, D. E., Osborn, O., Huang, Z., Liu, W., Yoshihara, E., van Dijk, T. H., et al. (2014) · Nature · doi:10.1038/nature13540 · Cited by 259

Fibroblast growth factors: key players in regeneration and tissue repair.

Maddaluno, L., Urwyler, C., & Werner, S. (2017) · Development · doi:10.1242/dev.152587 · Cited by 241

FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547

Xie, L., Su, X., Zhang, L., Yin, X., Tang, L., Zhang, X., Xu, Y., Gao, Z., Liu, K., Zhou, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3898 · Cited by 240

Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease

Itoh, N. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1024-2 · Cited by 241

Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas

Basu-Roy, U., Seo, E., Ramanathapuram, L. V., Rapp, T. B., Perry, J. A., Orkin, S. H., Mansukhani, A., & Basilico, C. (2011) · Oncogene · doi:10.1038/onc.2011.405 · Cited by 239

Fibroblast growth factor (FGF) signaling in development and skeletal diseases

Teven, C. M., Farina, E. M., Rivas, J., & Reid, R. R. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.005 · Cited by 237

Acute and Impaired Wound Healing

Demidova‐Rice, T. N., Hamblin, M. R., & Herman, I. M. (2012) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000418541.31366.a3 · Cited by 240

Recent therapeutic trends and promising targets in triple negative breast cancer

Hwang, S., Park, S., & Kwon, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.006 · Cited by 239

Signal transduction in vasculogenesis and developmental angiogenesis

Patel-Hett, S. R., & D'Amore, P. A. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103213sp · Cited by 241

Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis

BonDurant, L. D., & Potthoff, M. J. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064800 · Cited by 222

Cytokine networking of innate immunity cells: a potential target of therapy

Střı́ž, I., Brabcová, E., Kolesár, L., & Sekerková, A. (2014) · Clinical Science · doi:10.1042/cs20130497 · Cited by 231

FGF19 action in the brain induces insulin-independent glucose lowering

Morton, G. J., Matsen, M. E., Bracy, D. P., Meek, T. H., Hồng, N. T., Stefanovski, D., Bergman, R. N., Wasserman, D. H., & Schwartz, M. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70710 · Cited by 218

Regenerative Skin Wound Healing in Mammals: State-of-the-Art on Growth Factor and Stem Cell Based Treatments

Borena, B. M., Martens, A., Broeckx, S. Y., Meyer, E., Chiers, K., Duchateau, L., & Spaas, J. H. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374049 · Cited by 217

Trends and Challenges in Tumor Anti-Angiogenic Therapies

Jászai, J., & Schmidt, M. H. H. (2019) · Cells · doi:10.3390/cells8091102 · Cited by 215

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies

Akl, M. R., Nagpal, P., Ayoub, N. M., Tai, B., Prabhu, S. A., Capac, C. M., Gliksman, M., Goy, A. H., & Suh, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.8203 · Cited by 212

Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.

Angelin, B., Larsson, T., & Rudling, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.001 · Cited by 210

The Impact of Diabetes and Diabetes Medications on Bone Health

Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 211

Fibroblast growth factor control of cartilage homeostasis

Ellman, M. B., Yan, D., Ahmadinia, K., Chen, D., An, H. S., & Im, H.-J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24418 · Cited by 208

The Anti-Scar Effects of Basic Fibroblast Growth Factor on the Wound Repair In Vitro and In Vivo

Shi, H., Lin, C., Lin, B., Wang, Z., Zhang, H., Wu, F., Cheng, Y. H., Xiang, L., Di-Jiong, G., Luo, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059966 · Cited by 210

Bile Acids and FXR: Novel Targets for Liver Diseases

Stofan, M., & Guo, G. L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00544 · Cited by 214

FGFR a promising druggable target in cancer: Molecular biology and new drugs

Porta, R., Borea, R., Coelho, A., Khan, S., Araújo, A., Reclusa, P., Franchina, T., Steen, N. V. D., van Dam, P. A., Ferri, J., et al. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.018 · Cited by 201

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach

Presta, M., Chiodelli, P., Giacomini, A., Rusnati, M., & Ronca, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.013 · Cited by 200

Cell sheet tissue engineering: Cell sheet preparation, harvesting/manipulation, and transplantation

Kobayashi, J., Kikuchi, A., Aoyagi, T., & Okano, T. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36627 · Cited by 199

De-regulated FGF receptors as therapeutic targets in cancer

Knights, V., & Cook, S. J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.10.001 · Cited by 201

Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy

Gacche, R. N., & Meshram, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.002 · Cited by 203

Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors

Chow, W. S., Xu, A., Woo, Y. C., Tso, A. W. K., Cheung, S., Fong, C. H.-Y., Tse, H., Chau, M. T., Cheung, B. M. Y., & Lam, K. S. L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301599 · Cited by 193

Signaling Pathways Governing Tumor Angiogenesis

Sakurai, T., & Kudo, M. (2011) · Oncology · doi:10.1159/000333256 · Cited by 193

FGFR2 gene amplification and clinicopathological features in gastric cancer

Matsumoto, K., Arao, T., Hamaguchi, T., Shimada, Y., Kato, K., Oda, I., Taniguchi, H., Koizumi, F., Yanagihara, K., Sasaki, H., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.603 · Cited by 192

Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors

Lee, J., Su, S.-Y., Changou, C. A., Yang, R., Tsai, K., Collins, M. T., ORWOLL, E. S., Lin, C., Chen, S., Shih, S., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.137 · Cited by 186

Fibroblast growth factor signalling in osteoarthritis and cartilage repair

Xie, Y., Zinkle, A., Chen, L., & Mohammadi, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0469-2 · Cited by 186

Mechanisms of FGFR-mediated carcinogenesis

Ahmad, I., Iwata, T., & Leung, H. Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.004 · Cited by 188

FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways

Wu, A.-L., Coulter, S., Liddle, C., Wong, A., Eastham‐Anderson, J., French, D. M., Peterson, A. S., & Sonoda, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017868 · Cited by 185

Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19

Zhou, M., Wang, X., Phung, V., Lindhout, D. A., Mondal, K., Hsu, J.-Y., Yang, H., Humphrey, M., Ding, X., Arora, T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0208 · Cited by 183

FGF-dependent regulation of VEGF receptor 2 expression in mice

Murakami, M., Nguyen, L. T., Hatanaka, K., Schachterle, W., Chen, P., Zhuang, Z. W., Black, B. L., & Simons, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44762 · Cited by 187

Endocrine Protection of Ischemic Myocardium by FGF21 from the Liver and Adipose Tissue

Liu, S. Q., Roberts, D., Kharitonenkov, A., Zhang, B., Hanson, S., Li, Y. C., Zhang, L., & Wu, Y. (2013) · Scientific Reports · doi:10.1038/srep02767 · Cited by 179

Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin)

STEVENSON, W. C., Cheng, S.-F., Dastjerdi, M. H., Ferrari, G., & Dana, R. (2012) · The Ocular Surface · doi:10.1016/j.jtos.2012.01.005 · Cited by 185

Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile

Lin, Z., Wu, Z., Yin, X., Liu, Y., Yan, X., Lin, S., Xiao, J., Wang, X., Feng, W., & Li, X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015534 · Cited by 179

Oxidative Stress, Diabetes, and Diabetic Complications

Wei, W., Liu, Q., Tan, Y., Liu, L., Li, X., & Cai, L. (2009) · Hemoglobin · doi:10.3109/03630260903212175 · Cited by 178

Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies

Liu, W., Liu, S., Li, P., & Yao, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094883 · Cited by 192

Neuron and microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κB-dependent neuroinflammation to improve functional recovery after spinal cord injury

Chen, J., Wang, Z., Zheng, Z., Chen, Y., Khor, S., Shi, K., He, Z., Wang, Q., Zhao, Y., Zhang, H., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.490 · Cited by 176

Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering

Fujioka‐Kobayashi, M., Ota, M. S., Shimoda, A., Nakahama, K., Akiyoshi, K., Miyamoto, Y., & Iseki, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.075 · Cited by 173

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB

Yang, C., Jin, C., Li, X., Wang, F., McKeehan, W. L., & Luo, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033870 · Cited by 173

Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism

Marcelin, G., Jo, Y., Li, X., Schwartz, G. J., Zhang, Y., Dun, N. J., Lyu, R., Blouet, C., Chang, J. K., & Chua, S. C. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.10.002 · Cited by 168

Platelet-Rich Plasma Greatly Potentiates Insulin-Induced Adipogenic Differentiation of Human Adipose-Derived Stem Cells Through a Serine/Threonine Kinase Akt-Dependent Mechanism and Promotes Clinical Fat Graft Maintenance

Cervelli, V., Scioli, M. G., Gentile, P., Doldo, E., Bonanno, E., Spagnoli, L. G., & Orlandi, A. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0052 · Cited by 169

Gut microbiota–bile acid–skeletal muscle axis

Mancin, L., Wu, G. D., & Paoli, A. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.10.003 · Cited by 183

Going Back to the Biology of FGF21: New Insights

Lewis, J. E., Ebling, F. J. P., Samms, R. J., & Tsintzas, K. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.05.007 · Cited by 170

The Critical Role of Growth Factors in Gastric Ulcer Healing: The Cellular and Molecular Mechanisms and Potential Clinical Implications

Tarnawski, A. S., & Ahluwalia, A. (2021) · Cells · doi:10.3390/cells10081964 · Cited by 165

Impact of microRNAs on ischemic stroke: From pre- to post-disease

Li, G., Morris-Blanco, K. C., Lopez, M. S., Yang, T., Zhao, H., Vemuganti, R., & Luo, Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.002 · Cited by 159

Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2

Lin, C., Melo, F. A., Ghosh, R., Suen, K. M., Stagg, L., Kirkpatrick, J., Arold, S. T., Ahmed, Z., & Ladbury, J. E. (2012) · Cell · doi:10.1016/j.cell.2012.04.033 · Cited by 156

FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice

Wang, Q., Yuan, J., Yu, Z., Lin, L., Jiang, Y., Cao, Z., Zhuang, P., Whalen, M. J., Song, B., Wang, X., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0663-7 · Cited by 157

Roles of FGF signaling in stem cell self-renewal, senescence and aging

Coutu, D. L., & Galipeau, J. (2011) · Aging · doi:10.18632/aging.100369 · Cited by 161

FGF Family: From Drug Development to Clinical Application

Hui, Q., Jin, Z., Li, X., Liu, C., & Wang, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071875 · Cited by 182

Therapeutic uses of FGFs

Zhang, J., & Li, Y. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.007 · Cited by 44

FGF-based drug discovery: advances and challenges

Chen, G., Chen, L., Li, X., & Mohammadi, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01125-w · Cited by 51

成纤维细胞生长因子家族：生物学特性，病理生理学作用及相关治疗方法

时小燕, & 郭靓 (2009)

Pathology and Therapeutic Significance of Fibroblast Growth Factors

Edirisinghe, O., Ternier, G., & Kumar, T. K. S. (2025) · Targets · doi:10.3390/targets3010005 · Cited by 8